Assertio increases acquisition price to $21.80/share all cash; Garda's revised offer up 21.1%

Assertio Holdings, Inc.

Offer price $21.80/share in cash, no CVR, up from $18 plus CVR (21.1% premium to original offer).
Premium of 63.1% to unaffected stock price on March 20, 2026; total equity value ~$153.2M.
Board unanimously approved; tender offer to commence by May 4, 2026; closing expected Q2 2026.
Financing commitments fully committed: $22.2M equity (Limber and Lund) and up to $130M debt (Colbeck).
Company withdraws 2026 guidance and cancels Q1 2026 earnings conference call due to pending transaction.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Assertio Holdings, Inc. amended Amended and Restated Agreement and Plan of Merger with Garda Therapeutics, Inc. and Audi Merger Sub, Inc. (effective 2026-05-01).

Action: amendment
Agreement: merger
Counterparty: Garda Therapeutics, Inc. and Audi Merger Sub, Inc.
Effective: 2026-05-01

Exact text from the filing

On May 1, 2026, Assertio Holdings, Inc. (the “ Company ” or “ Assertio ”) entered into an Amended and Restated Agreement and Plan of Merger (the “ Amended and Restated Merger Agreement ”) with Garda Therapeutics, Inc., a Delaware corporation (“ Parent ”), and Audi Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“ Purchaser ”), which amends and restates in its entirety the Agreement and Plan of Merger, dated as of April 8, 2026 (the “ Original Merger Agreement ”), by and among the Company, Parent and Purchaser.

View on SEC.gov

Browse all material agreements →

Assertio Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-26-054488

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.